Navigation Links
Researcher helping to pioneer medical therapy for Fragile X Syndrome presents latest findings
Date:7/18/2008

(CHICAGO) Neurological experts from across the U.S. and other countries including a nationally renowned researcher from Rush University Medical Center will discuss the latest findings in basic and clinical research for Fragile X at the 11th International Fragile X Conference, to be held July 23-27 in St. Louis. Families with children who are diagnosed with Fragile X also will be attending the conference.

Fragile X, an X-chromosome-linked condition, is the most common inherited cause of mental retardation and the most common known cause of autism or autistic-like behaviors.

Rush's Dr. Elizabeth Berry-Kravis, will be leading a number of discussions at the conference including a plenary session on promising new treatments and clinical sessions on stem cell research, seizures and psychopharmacology. In addition, she will be presenting research on the use of lithium to target the underlying defect in Fragile X Syndrome.

Dr. Berry-Kravis runs the only Fragile X clinic in Chicago and one of the few in the Midwest. Her research program also includes studies of fragile X-associated tremor/ataxia syndrome (FXTAS), a degenerative neurological condition which occurs in fragile X mutation carriers, and she will be presenting research on development of new methods for evaluating risk for FXTAS using a state-of-the-art imaging technique called diffusion tensor imaging.

Schedule of scientific and family friendly sessions led by Dr. Berry-Kravis include:

Plenary sessions:

  • New Treatments on the Near Horizon, Thursday, July 24, 9:45 a.m.
  • Seizure Disorders, Saturday, July 26, 2:45 p.m
  • Five Current Topics of Interest in Psychopharmacology of FXS, Saturday, July 26, 11 a.m.

Research abstract presentations:

  • FXTAS (Fragile X-Associated Tremor/Ataxia Syndrome)
    • Diffusion Tensor Imaging in Male FMR1 Premutation Carriers With and Without FXTAS, Wednesday, July 23, 1:30 p.m.
  • Fragile X Syndrome (FXS)
    • Vocabulary Comprehension in FXS, Wednesday, July 23, 4 p.m.
    • ERK Activation Kinetics as a Biomarker for Metabolic Status in FXS, Saturday, July 26, 9:45 a.m.
  • Medications
    • Open Label Treatment Trial of Lithium to Target the Underlying Defect in FXS

    • Fragile X Conference

    • Atypical Autonomic Regulation in FXS: Contrasts with Normal and Effects of Lithium, Saturday, July 26 1:30 p.m.

Scientific-clinical panel sessions:

  • A Conversation with the Experts: Drug Trials and Adults with -Developmental DisabilitiesEthical Issues and Informed Consent, Thursday, July 24, 11 a.m.
  • Stem Cell Research and Its Implications for Fragile X Research and Treatment, Thursday, July 24, 1:30 p.m.

Family-friendly panel sessions:

  • Psychopharmacology Q & A, Sunday, July 29, 9 a.m.
  • Questions, Answers and Difficult Cases: Treatment Issues, Sunday, July 27, 10:30 a.m.


'/>"/>

Contact: Deb Song
deb_song@rush.edu
312-942-0588
Rush University Medical Center
Source:Eurekalert

Related biology news :

1. As rates rise, researchers find better way to identify melanoma
2. Researchers discover a gene that regulates and blocks ovulation
3. Researchers discover link between organ transplantation and increased cancer risk
4. Dartmouth researchers discover gene signatures for scleroderma
5. URI researcher: China cant fully fix air quality problem for Olympics
6. Louisiana Tech researchers feature drug reformulation in prestigious journal
7. UCLA researchers locate and image prostate cancer as it spreads to lymph nodes
8. UCSB researcher leads worldwide study on marine fossil diversity
9. Researchers catch ion channels in their opening act
10. UGA researchers discover mechanism that explains how cancer enzyme winds up on ends of chromosomes
11. Researchers hack final part of the immune system code
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/13/2016)... CHICAGO , April 13, 2016  IMPOWER physicians ... are setting a new clinical standard in telehealth ... By leveraging the higi platform, IMPOWER patients can ... weight, pulse and body mass index, and, when they ... quick and convenient visit to a local retail location ...
(Date:3/29/2016)... 29, 2016 LegacyXChange, Inc. (OTC: ... and SelectaDNA/CSI Protect are pleased to announce our successful ... a variety of writing instruments, ensuring athletes signatures against ... collectibles from athletes on LegacyXChange will be assured of ... DNA. Bill Bollander , CEO states, ...
(Date:3/22/2016)... Ontario , PROVO and ... Newborn Screening Ontario (NSO), which operates the ... for molecular testing, and Tute Genomics and UNIConnect, ... management technology respectively, today announced the launch of a ... next-generation sequencing (NGS) testing panel. NSO ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... ... June 24, 2016 , ... Researchers at the Universita ... miRNAs in people with peritoneal or pleural mesothelioma. Their findings are the subject of ... now. , Diagnostic biomarkers are signposts in the blood, lung fluid or tissue ...
(Date:6/23/2016)... June 23, 2016 A person commits a crime, ... scene to track the criminal down. An outbreak ... and Drug Administration (FDA) uses DNA evidence to track down ... Sound far-fetched? It,s not. The FDA has increasingly used ... investigations of foodborne illnesses. Put as simply as possible, whole ...
(Date:6/23/2016)... , June 23, 2016   EpiBiome , a ... $1 million in debt financing from Silicon Valley Bank ... automation and to advance its drug development efforts, as ... facility. "SVB has been an incredible strategic ... services a traditional bank would provide," said Dr. ...
(Date:6/23/2016)... 2016  Blueprint Bio, a company dedicated to identifying, ... community, has closed its Series A funding round, according ... "We have received a commitment from Forentis Fund ... to meet our current goals," stated Matthew Nunez ... to complete validation on the current projects in our ...
Breaking Biology Technology: